Current Diabetes Trials

MannKind Conducting Clinical Trials for Technosphere®/Inhaled Insulin

The body’s initial response to rising blood sugar after a meal is a rapid release of insulin from the pancreas. In those with diabetes, this rapid release of insulin is limited or lost. In people with type 1 diabetes, the pancreas no longer makes insulin at all. People with type 2 diabetes are able to make insulin, but their bodies don’t respond well to it. In these studies, doctors are testing an investigational rapid-onset insulin powder that is inhaled through a pocket-sized device.

For more information or to enroll, visit www.clinicaltrials.gov